Une candidature sur mesure pour ce poste — un CV personnalisé et une lettre de motivation qui correspondent directement à l’offre.
Oxford Nanopore Technologies is seeking an experienced BioPharma Senior Sales Specialist to accelerate adoption across the pharmaceutical and biotechnology sector in EMEAI, with frequent travel. This role can be based in France, Belgium, or the Netherlands.
The successful candidate will drive strategic growth across BioPharma accounts, collaborating with Field Sales and cross-functional teams to deliver sustainable revenue and expand nanopore sequencing applications in drug discovery,
Oxford Nanopore has developed a new generation of nanopore-based sensing technology for faster, information-rich, accessible and affordable molecular analysis, used to understand and characterise the biology of humans and diseases such as cancer. By enabling biological insights, we strive to improve life on Earth and beyond.
Oxford Nanopore Technologies is seeking an experienced and commercially driven BioPharma Senior Sales Specialist to accelerate the adoption and growth of our technology across the pharmaceutical and biotechnology sector in EMEAI. This role can be based in France, Belgium, or the Netherlands. Please note that this role involves frequent travel across EMEAI.
Reporting to theDirector Biopharma Sales, EMEAI. This Senior Sales Executive will be responsible for driving strategic growth across complex BioPharma accounts through advanced account mapping, proactive prospecting, and collaborative team-based selling. They will build strategic relationships with pharmaceutical and biotechnology organisations, and deliver sustainable revenue growth across the region.
The successful candidate will work closely with Field Sales and cross-functional colleagues across Business Development, Applications, Technical Support, Marketing, Market Development and Product teams to identify, develop and accelerate high-value Biopharma opportunities.
You will be an experienced senior commercial professional with a strong understanding of the pharmaceutical and biotechnology sector and a track record of developing complex, strategic customer relationships and delivering revenue growth.
You will combine strategic thinking with hands-on commercial execution, be comfortable engaging stakeholders from scientists through to senior executives and be highly effective at influencing and coordinating across a matrix organisation.
Experience working with cross-functional teams to deliver and execute strategic deals.
A few years experience in genomics, sequencing, life sciences tools or technologies supporting pharmaceutical R&D would be highly advantageous.
This is an opportunity to play a significant role in expanding the use of Oxford Nanopore Technologies across the EMEAI Biopharma market, developing strategic customer partnerships and establishing nanopore sequencing as an increasingly important technology across pharmaceutical and biotechnology research and development.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information-rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.